Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies

Gastroenterology Clinics of North America

Volumn 35, Issue 1, 2006, Pages 53-64

  Hassan, Imran ^a   Cima, Robert C ^a   Sloan, Jeff A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CAPECITABINE; CISPLATIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RALTITREXED;

ABDOMINAL PAIN; ADVANCED CANCER; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIARRHEA; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FUNCTION; INTRAOPERATIVE RADIOTHERAPY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NEUROTOXICITY; OBSTRUCTION; PALLIATIVE THERAPY; PELVIS PAIN SYNDROME; PERFORATION; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE; UNSPECIFIED SIDE EFFECT; UROGENITAL SYSTEM;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 33644824746     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2005.12.010     Document Type: Review

References (62)

1. M. Michael, and I.F. Tannock Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment CMAJ 158 13 1998 1727 1734
2. B.H. Osse, M.J. Vernooij, and E. Schade Towards a new clinical tool for needs assessment in the palliative care of cancer patients: the PNPC instrument J Pain Symptom Manage 28 4 2004 329 341
3. World Health Organization Technical report series 804 Cancer Pain and Palliative Care 1990 World Health Organization Geneva 11
4. P.B. Jacobsen, and M.A. Weitzner Evaluation of palliative endpoints in oncology clinical trials Cancer Control 6 5 1999 471 477
5. M.J. Brady, and D. Cella Assessing quality of life in palliative care Cancer Treat Res 100 1999 203 216
6. D.F. Cella Quality of life: the concept J Palliat Care 8 3 1992 8 13
7. G.F. Whalen, and C.E. Ferrans Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons J Surg Oncol 77 4 2001 270 276
8. M.H. Frost, and J.A. Sloan Quality of life measurements: a soft outcome - or is it? Am J Manag Care 8 Suppl 18 2002 S574 S579
9. D.F. Cella Quality of life outcomes: measurement and validation Oncology 10 Suppl 11 1996 S233 S246
10. S.R. Cohen Defining and measuring quality of life in palliative care Journal of Palliative Care 5 2001 137 156
11. M. Dijkers Measuring quality of life: methodological issues Am J Phys Med Rehabil 78 3 1999 286 300
12. B.R. Ferrell, K.H. Dow, and M. Grant Measurement of the quality of life in cancer survivors Qual Life Res 4 6 1995 523 531
13. National Institutes of Health Consensus Development Program. Draft statement, symptom management in cancer: pain, depression, and fatigue. Statement of the Science Conference: July 15-17, 2002.
14. O. Chassany, P. Sagnier, and P. Marquis Patient reported outcomes: the example of health related quality of life - a european guidance for the improved integration of HRQoL assessment in the drug regulatory process Drug Inf J 36 2002 209 238
15. P.M. Fayers, P. Hopwood, and A. Harvey Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: the UK medical research council experience Eur J Cancer 33 1 1997 20 28
16. J.A. Sloan, D. Cella, M. Frost for the Clinical Significance Consensus Meeting Group Assessing clinical significance in measuring oncology patient quality of life Mayo Clin Proc 77 2002 367 370
17. J.A. Sloan, N. Aaronson, J.C. Cappelleri for the Clinical Significance Consensus Meeting Group Assessing the clinical significance of single items relative to summated scores Mayo Clin Proc 77 2002 479 487
18. J.A. Sloan, C.L. Loprinzi, and S.A. Kuross Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer J Clin Oncol 16 1998 3662 3673
19. J. Sloan, T. Symonds, and D. Vargas-Chanes Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials Drug Inf J 37 2003 23 31
20. J.A. Sloan Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions Journal of Chronic Obstructive Pulmonary Disease 2 2005 57 62
21. J.A. Sloan, D. Vargas-Chanes, and C.C. Kamath Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures J Cancer Integrative Medicine 1 1 2003 41 47
22. G.H. Guyatt, D. Osoba, A.W. Wu for the Clinical Significance Consensus Meeting Group Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 4 2002 371 383
23. G.R. Norman, J.A. Sloan, and K.W. Wyrwich The truly remarkable universality of half a standard deviation: confirmation through another look Expert Review of Pharmacoeconomics and Outcomes Research 4 5 2004 515 519
24. J.A. Sloan, and A. Dueck Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials J Biopharm Stat 14 1 2004 73 96
25. J.A. Sloan, A. Dueck, and M. Frost Solutions for assessing quality of life in cancer research and clinical practice: part 1 Curr Probl Cancer 29 2005 265 351
26. D. Osoba, A. Bezjak, M. Brundage for the Quality of Life Committee of the NCIC CTG Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group Eur J Cancer 41 2 2005 280 287
27. A. Bottomley, V. Vanvoorden, H. Flechtner for the EORTC Quality of Life Group EORTC Data Center The challenges and achievements involved in implementing quality of life research in cancer clinical trials Eur J Cancer 39 3 2003 275 285
28. D.A. Osoba Taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results Med Care 40 Suppl 6 2002 SIII-31 SIII-38
29. D.F. Cella, D.S. Tulsky, and G. Gray The functional assessment of cancer therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
30. S.B. Yellen, D.F. Cella, and K. Webster Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system J Pain Symptom Manage 13 2 1997 63 74
31. T.F. Kozelsky, G.E. Meyers, and J.A. Sloan Phase 3 double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy J Clin Oncol 21 9 2003 1669 1674
32. J. De Haes, D. Curran, and T. Young Quality of life evaluation in oncological clinical trials: the EORTC model Eur J Cancer 36 2000 821 825
33. T.R. Mendoza, X.S. Wang, and C.S. Cleeland The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory Cancer 85 5 1999 1186 1196
34. K. Ahlberg, T. Ekman, and F. Gaston-Johansson Assessment and management of cancer-related fatigue in adults Lancet 362 2003 640 650
35. I. Bjelland, A.A. Dahl, and T. Tangen Haug The validity of the hospital anxiety and depression scale: an updated literature review J Psychosom Res 52 2002 69 77
36. D.M. McNair, M. Lorr, and L.F. Droppleman Edits manual for the profile of mood states [revised 1992] 1992 Edits/Educational and Industrial Testing Service San Diego (CA)
37. Sloan JA, et al. Quality of life, spirituality, and mayo franciscan values: a research perspective. Mayo Clin Proc, in press.
38. J.E. Ware Jr., V. Gandek, and M. Kosinski The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA project J Clin Epidemiol 51 11 1998 1167 1170
39. J.E. Ware Jr., M. Kosinski, and S.D. Keller A 12-item short-form health survey Med Care 34 1996 220 233
40. S.A. Rosen, J.F. Buell, and A. Yoshida Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135 5 2000 530 535 [discussion: 534-5]
41. F. Amersi, M.J. Stamos, and C.Y. Ko Palliative care for colorectal cancer Surg Oncol Clin N Am 13 3 2004 467 477
42. P.C. Simmonds for the Colorectal Cancer Collaborative Group Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis BMJ 321 7260 2000 531 535
43. N.M. Ellison Palliative chemotherapy Am J Hosp Palliat Care 15 2 1998 93 103
44. W. Scheithauer, H. Rosen, and G.V. Kornek Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer BMJ 306 6880 1993 752 755
45. D. Cunningham, S. Pyrhonen, and R.D. James Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 9138 1998 1413 1418
46. A.F. Sobrero, C. Aschele, and J.R. Bertino Fluorouracil in colorectal cancer-a tale of two drugs: implications for biochemical modulation J Clin Oncol 15 1 1997 368 381
47. T.S. Maughan, R.D. James, and D.J. Kerr Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial Lancet 359 9317 2002 1555 1563
48. A. de Gramont, J.F. Bosset, and C. Milan Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol 15 2 1997 808 815
49. R.M. Goldberg, D.J. Sargent, and R.F. Morton A randomized control trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23 30
50. Morton RF, Sloan JA, Grothey A, et al. A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. ASCO. Orlando, Florida; May 13-17, 2005. Abstract 8087.
51. P.W. Carne, J.N. Frye, and G.M. Robertson Stents or open operation for palliation of colorectal cancer: A retrospective, cohort study of perioperative outcome and long-term survival Diseases of the Colon & Rectum 47 9 2004 1455 1461
52. M. Hunerbein, M. Krause, and K.T. Moesta Palliation of malignant rectal obstruction with self-expanding metal stents Surgery 137 2005 42 47
53. G.H. Mannaerts, H. Martijn, and M.A. Crommelin Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma Int J Radiat Oncol Biol Phys 45 2 1999 297 308
54. A.R. Miller, S.B. Cantor, and G.E. Peoples Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer Dis Colon Rectum 43 12 2000 1695 1703
55. G.H. Mannaerts, H.J. Rutten, and H. Martijn Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer Dis Colon Rectum 44 12 2001 1749 1758
56. K. Lindel, C.G. Willett, and P.C. Shellito Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer Radiother Oncol 58 1 2001 83 87
57. D. Hahnloser, M.G. Haddock, and H. Nelson Intraoperative radiotherapy in the multimodality approach to colorectal cancer Surg Oncol Clin N Am 12 4 2003 993 1013
58. M. Shoup, J.G. Guillem, and K.M. Alektiar Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy Dis Colon Rectum 45 5 2002 585 592
59. J.N. Wiig, J.P. Poulsen, and K.M. Tveit Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer: a need for randomised studies Eur J Cancer 36 7 2000 868 874
60. G.H. Mannaerts, H.J. Rutten, and H. Martijn Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer Int J Radiat Oncol Biol Phys 54 4 2002 1082 1088
61. N.F. Esnaola, S.B. Cantor, and M.L. Johnson Pain and quality of life after treatment in patients with locally recurrent rectal cancer J Clin Oncol 20 21 2002 4361 4367
62. D. Shibata, J.G. Guillem, and N. Lanouette Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation Dis Colon Rectum 43 6 2000 752 758